Practical guidelines for the clinical use of plasma

Thrombosis Research

Volumn 107, Issue SUPPL., 2002, Pages

  Hellstern, Peter ^a   Muntean, Wolfgang ^b   Schramm, Wolfgang ^c   Seifried, Erhard ^d   Solheim, Bjarte G ^e  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Institute of Transfusion Medicine and Immunohematology   (Germany)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Contra indications; ECMO, extracorporeal membrane oxygenation; Indications; Plasma; Side effects

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; CITRIC ACID;

ALLERGIC REACTION; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD DISEASE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EXTRACORPOREAL OXYGENATION; FEVER; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERBILIRUBINEMIA; HYPERVOLEMIA; LABORATORY TEST; LIVER DISEASE; LUNG INJURY; PLASMA; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; STANDARDIZATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOXICITY; TREATMENT CONTRAINDICATION; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; HOMEOSTASIS; INSTRUMENT STERILIZATION; METHODOLOGY; STANDARD;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; HEMORRHAGE; HOMEOSTASIS; HUMANS; LIVER DISEASES; PLASMA; PRACTICE GUIDELINES; STERILIZATION;

EID: 0037206604     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00153-6     Document Type: Conference Paper

References (17)

1. Fredrikkson K., Norrving B., Stromblad L.G. Emergency reversal of anticoagulation after intracerebral hemorrhage. Acta Neurol. Scand. 23:1992;972-977.
2. Makris M., Greaves M., Phillips W.S., Kitchen S., Rosendaal F.R., Preston E.F. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb. Haemost. 77:1997;477-480.
3. Pindur G., Mörsdorf S. The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. Thromb. Res. 95:1999;S57-S61.
4. Boulis N.M., Bobek M.P., Schmaier A., Hoff J.T. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 45:1999;1113-1118.
5. Cartmill M., Dolan G., Byrne J.L., Byrne P.O. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br. J. Neurosurg. 14:2000;458-461.
6. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force Guidelines for the use of fresh frozen plasma. Transfus. Med. 2:1992;57-63.
7. Task Force of the College of American Pathologists Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA. 271:1994;777-781.
8. American Society of Anesthesiologists Task Force on Blood Component Therapy Practice guidelines for blood component therapy. Anesthesiology. 84:1996;732-747.
9. Medical Directors Advisory Committee, National Blood Transfusion Council South Africa Guidelines for the use of fresh-frozen plasma. SAMJ. 88:1998;1344-1347.
10. Leslie S.D., Toy P.T.C.Y. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am. J. Clin. Pathol. 96:1991;770-773.
11. Murray D.J., Pennell B.J., Weinstein S.L., Olson J.D. Packed red cells in acute blood loss: dilution coagulopathy as a cause of surgical bleeding. Anesth. Analg. 80:1995;336-340.
12. Hiippala S. Replacement of massive blood loss. Vox Sang. 74(Suppl. 2):1998;399-407.
13. Presidency of the European Union/Federal Ministry of Health/Commission of the European Communities. Blood safety in the European community: an initiative for optimal use. Wildbad Kreuth: Conference Proceedings, Syllabus - Fresh frozen plasma. p. 12-7, p. 40-3, p. 69-71, p. 119-26, 1999.
14. Rohrer M.J., Natale A.M. Effect of hypothermia on the coagulation cascade. Crit. Care Med. 20:1992;1402-1405.
15. Hiippala S.T. Dextran and hydroxyethylstarch interfere with fibrinogen assays. Blood Coagul. Fibrinolysis. 81:1995;360-365.
16. Levi M., de Jonge E., van der Poll T., ten Cate H. Disseminated intravascular coagulation. Thromb. Haemost. 82:1999;695-705.
17. de la Rubia J., Arriaga F., Linares D., Larrea L., Carpio N., Marty M.L.et al. Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. Br. J. Haematol. 114:2001;721-723.